NCT01951066View on ClinicalTrials.gov

Diabetic Macular Edema Treated With Ozurdex (DMEO)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Diabetic Macular Edema
Interventions
DRUG

Dexamethasone Implant

Patients will receive a single injection of a dexmethasone implant

DRUG

Anti-VEGF injection

Patients will receive PRN injections of an anti-VEGF agent

Trial Locations (1)

21287

Wilmer Eye Institute, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT01951066 - Diabetic Macular Edema Treated With Ozurdex (DMEO) | Biotech Hunter | Biotech Hunter